| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/16/2001 | WO2001059072A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001059070A1 Production method of recombinant rotavirus structural proteins and vaccine composition |
| 08/16/2001 | WO2001059066A2 Protein design automation for protein libraries |
| 08/16/2001 | WO2001059064A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001059063A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058953A2 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058946A2 Polynucleotides and polypeptides encoded thereby |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 08/16/2001 | WO2001058943A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 08/16/2001 | WO2001058942A1 Antimicrobial peptides isolated from the skin of the hyperoliid frog, kassina senegalensis |
| 08/16/2001 | WO2001058941A1 Cytokine activity regulator molecules from tick salivary glands |
| 08/16/2001 | WO2001058940A2 Adenoviral capsid containing chimeric protein ix |
| 08/16/2001 | WO2001058939A2 Novel invertase inhibitors and methods of use |
| 08/16/2001 | WO2001058938A2 Human neurexin-like proteins and polynucleotides encoding the same |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058923A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 08/16/2001 | WO2001058922A2 Method and compositions for treating hepatocellular cancer |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058918A2 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058494A2 Gene therapy for treating ocular-related disorders |
| 08/16/2001 | WO2001058484A2 Novel uses of mammalian ccr8 receptors and related reagents |
| 08/16/2001 | WO2001058482A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 08/16/2001 | WO2001058479A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | WO2001058478A1 Antigenic complexes and methods |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001058255A1 Chimeric animal containing human blood |
| 08/16/2001 | WO2001027282A8 Plant virus particles with exogenous internal eitopes |
| 08/16/2001 | WO2001024773B1 Liposome-entrapped dna oral vaccines |
| 08/16/2001 | WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues |
| 08/16/2001 | WO2001023416A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 08/16/2001 | WO2001012201A8 Blood plasma replacement solution |
| 08/16/2001 | WO2001012172B1 Treatment of metastatic disease |
| 08/16/2001 | WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2001009389A3 Methods and apparatus for template capture and normalization for submicroliter reaction |
| 08/16/2001 | WO2001009385A3 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids |
| 08/16/2001 | WO2001009347A3 Archaeal replication accessory factors and methods of use |
| 08/16/2001 | WO2001009311A9 Methods of inhibiting cancer cells with adnf iii antisense oligonucleotides |
| 08/16/2001 | WO2001009293A3 Mammalian adhesion protease peptides |
| 08/16/2001 | WO2001009292A3 Sentrin-specific human proteases senp1-3 |
| 08/16/2001 | WO2001009185A3 Transmembrane transport proteins, nucleic acids encoding them and uses therefor |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001007591A3 Dna sequences which code export systems |
| 08/16/2001 | WO2001007583A8 Cell/tissue analysis via controlled electroporation |
| 08/16/2001 | WO2001006989A3 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 08/16/2001 | WO2001004354A3 Use of ras inhibitors of inhibiting muscle atrophy |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2001002556A3 Agents for the diagnosis, prognosis and treatment of malignant diseases |
| 08/16/2001 | WO2000079008A3 High throughput assay system |
| 08/16/2001 | WO2000078983A3 Sunflower anti-pathogenic proteins and genes and their uses |
| 08/16/2001 | WO2000071732A3 Nucleotide sequence for increasing the defense reaction of a plant against infection by a pathogen |
| 08/16/2001 | WO2000070556A3 A method and relational database management system for storing, comparing, and displaying results produced by analyses of gene array data |
| 08/16/2001 | WO2000065055A8 Human transporter proteins |
| 08/16/2001 | WO2000058506A3 Susceptibility to psoriasis |
| 08/16/2001 | WO2000058352A3 Barley gene for thioredoxin and nadp-thioredoxin reductase |
| 08/16/2001 | WO2000055307A3 A method for increasing the processivity of a dna- or rna-dependent polymerase and compositions therefor |
| 08/16/2001 | WO2000049132A3 Uses of transgenic animals containing a type x collagen mutant |
| 08/16/2001 | WO2000046367A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | WO2000044782B1 Ewing's tumour antigen, nucleic acid and antibodies |
| 08/16/2001 | WO2000036093A9 Intein-mediated cyclization of peptides |
| 08/16/2001 | WO2000023603A9 Methods of treatment of type 2 diabetes |
| 08/16/2001 | WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/16/2001 | WO2000004156A3 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES) |
| 08/16/2001 | WO2000003025A3 Method of genetic modification of a wild type viral sequence |
| 08/16/2001 | US20010014977 DNA sequence encoding protein for pigment synthesis; modifying color phenotype of plant tissue |
| 08/16/2001 | US20010014734 Controllers |
| 08/16/2001 | US20010014732 Biocidal proteins |
| 08/16/2001 | US20010014673 Genetic engineering |
| 08/16/2001 | US20010014672 High molecular weight major outer membrane protein of moraxella |
| 08/16/2001 | US20010014650 Adsorption, desorption of targeted nucleic acids |
| 08/16/2001 | US20010014476 Region which allows its replication comprises an origin of replication derived from a plasmid or a bacteriophage and whose functionality in the host cell requires the presence of at least one specific protein foreign to host cell |
| 08/16/2001 | US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy |
| 08/16/2001 | US20010014471 Antitumor agents |
| 08/16/2001 | US20010014469 Comprising a cytotoxic agent and a pest gut epithelial cell recognition portion of a protein, said cytotoxic agent and recognition portion not being naturally contiguous |
| 08/16/2001 | US20010014468 Magnetic polymer particles on the basis of polyvinyl alcohol, process for the production and use |
| 08/16/2001 | US20010014467 Reacting trans-ferulic acid and coenzyme a (CoASH) under trans-ferulate:CoASH ligase enzyme activity, trans-feruloyl SCoA hydratase activity, and 4-hydroxy-3-methoxyphenyl-beta-hydroxypropionyl SCoA cleavage activity; Pseudomonas enzymes |
| 08/16/2001 | US20010014465 Human 4-1BB receptor splicing variant |
| 08/16/2001 | US20010014464 Nucleic acid encoding follistatin-3 |
| 08/16/2001 | US20010014461 For diagnosis, drug discovery; both parallel and muliplex analyte processing capabilities; retentate chromatography is a combinatorial method to provide high information resolution of analytes in complex mixtures |
| 08/16/2001 | US20010014460 Determining whether the Fc-gamma receptor allelic pattern of the patient corresponds most closely to known Fc-gamma allelic patterns of patients having severe, mild, or no autoimmune disease to determine susceptibility |
| 08/16/2001 | US20010014458 Human G-protein coupled receptor GPR6sb |
| 08/16/2001 | US20010014448 Reagent for covalent attachment of nucleic acids onto the surface of the substrate, comprising a polymer backbone having pendant thermochemically reactive groups; making activated slides for use in microarrays |
| 08/16/2001 | US20010014447 Methods for the detection of encysted parasites |
| 08/16/2001 | US20010014445 Contacting a biological sample from a patient with a nucleic acid which specifically hybridizes to a target human nucleic acid sequence and detecting the presence of the target sequence; diagnosis of chronic illness such as cancer |
| 08/16/2001 | US20010014444 Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted thereagainst |
| 08/16/2001 | US20010014335 A fusion protein comprising a polypeptide having antigenicity of Mycoplasma gallisepticum and a polypeptide derived from herpesvirus outer membrane protein being ligated with polypeptide having antigenicity of mycoplasma at N-terminum |
| 08/16/2001 | US20010014334 Methods and materials for the treatment of prostatic carcinoma |
| 08/16/2001 | US20010014333 Hybrid heterodimeric protein hormone and method of using same |